{"DataElement":{"publicId":"3452507","version":"2","preferredName":"Pancreatic Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for exocrine and endocrine pancreatic cancer.","longName":"3452385v1.0:3452475v1.1","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3452385","version":"1","preferredName":"Pancreas Neoplasm Stage Grouping","preferredDefinition":"A non-encapsulated elongated and lobulated organ, extending from the concavity of the duodenum to the spleen; it consists of a head, an elongated body, and a tail. It contains two functional components: an exocrine component that secretes juices into the intestine and an endocrine component that secretes hormones (insulin and glucagon)._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"3452357v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3452357","version":"1","preferredName":"Pancreas Neoplasm","preferredDefinition":"A non-encapsulated elongated and lobulated organ, extending from the concavity of the duodenum to the spleen; it consists of a head, an elongated body, and a tail. It contains two functional components: an exocrine component that secretes juices into the intestine and an endocrine component that secretes hormones (insulin and glucagon).:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12393:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreas","conceptCode":"C12393","definition":"An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79E0A4-6392-D3E2-E040-BB89AD4323E5","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"ONEDATA","dateModified":"2012-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BF79FA5D-4C3E-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"TAYLORT","dateModified":"2017-09-13","changeDescription":"9/13/17 tt transferred context; changed Reg Status to Qualified. Created for CRF standard harmonization. Released per final community approval. mc 5/15/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3452475","version":"1.1","preferredName":"Exocrine and Endocrine Pancreatic Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A finding about one or more characteristics of exocrine or endocrine pancreatic cancer, following the rules of the TNM AJCC v7 classification system.  Pancreatic neuroendocrine tumors (including carcinoid tumors) are now staged by a single pancreatic staging system. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3452475v1.1","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"Stage 0 Pancreatic Cancer","ValueMeaning":{"publicId":"3452477","version":"1","preferredName":"Stage 0 Pancreatic Cancer","longName":"3452477","preferredDefinition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Pancreatic Cancer AJCC v6 and v7","conceptCode":"C5729","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79FA5D-5094-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73D1D5A-D3DA-BF4E-E040-BB89AD431197","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73D1D5A-D313-BF4E-E040-BB89AD431197","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Pancreatic Cancer","ValueMeaning":{"publicId":"3452479","version":"1","preferredName":"Stage IA Pancreatic Cancer","longName":"3452479","preferredDefinition":"Stage IA includes: T1, N0, M0. T1: Tumor limited to the pancreas, 2 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Pancreatic Cancer AJCC v6 and v7","conceptCode":"C88100","definition":"Stage IA includes: T1, N0, M0. T1: Tumor limited to the pancreas, 2 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79FA5D-50BA-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73D1D5A-D3EE-BF4E-E040-BB89AD431197","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Pancreatic Cancer","ValueMeaning":{"publicId":"3452481","version":"1","preferredName":"Stage IB Pancreatic Cancer","longName":"3452481","preferredDefinition":"Stage IB includes: T2, N0, M0. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Pancreatic Cancer AJCC v6 and v7","conceptCode":"C88101","definition":"Stage IB includes: T2, N0, M0. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79FA5D-50E0-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73D1D5A-D402-BF4E-E040-BB89AD431197","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Pancreatic Cancer","ValueMeaning":{"publicId":"3452483","version":"1","preferredName":"Stage IIA Pancreatic Cancer","longName":"3452483","preferredDefinition":"Stage IIA includes: T3, N0, M0.  T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Pancreatic Cancer AJCC v6 and v7","conceptCode":"C88102","definition":"Stage IIA includes: T3, N0, M0.  T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79FA5D-5106-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73D1D5A-D416-BF4E-E040-BB89AD431197","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Pancreatic Cancer","ValueMeaning":{"publicId":"3452485","version":"1","preferredName":"Stage IIB Pancreatic Cancer","longName":"3452485","preferredDefinition":"Stage IIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0).  T1: Tumor limited to the pancreas, 2 cm or less in greatest dimension.  T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery.  N1: Regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Pancreatic Cancer AJCC v6 and v7","conceptCode":"C88103","definition":"Stage IIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0).  T1: Tumor limited to the pancreas, 2 cm or less in greatest dimension.  T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery.  N1: Regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79FA5D-512C-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73D1D5A-D42A-BF4E-E040-BB89AD431197","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Pancreatic Cancer","ValueMeaning":{"publicId":"3452487","version":"1","preferredName":"Stage III Pancreatic Cancer","longName":"3452487","preferredDefinition":"Stage III includes: T4, Any N, M0. T4: Tumor involves the celiac axis or the superior mesenteric artery.  M0: No distant metastasis.  (AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Pancreatic Cancer AJCC v6 and v7","conceptCode":"C7787","definition":"Stage III includes: T4, Any N, M0. T4: Tumor involves the celiac axis or the superior mesenteric artery.  M0: No distant metastasis.  (AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79FA5D-5152-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73D1D5A-D43E-BF4E-E040-BB89AD431197","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Pancreatic Cancer","ValueMeaning":{"publicId":"3452489","version":"1","preferredName":"Stage IV Pancreatic Cancer","longName":"3452489","preferredDefinition":"Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis. (AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Pancreatic Cancer AJCC v6 and v7","conceptCode":"C5711","definition":"Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis. (AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79FA5D-5178-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C73D1D5A-D452-BF4E-E040-BB89AD431197","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"ONEDATA","dateModified":"2012-08-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3452474","version":"1","preferredName":"Exocrine and Endocrine Pancreatic Cancer TNM Finding v7 American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A finding about one or more characteristics of exocrine or endocrine pancreatic cancer, following the rules of the TNM AJCC v7 classification system.  Pancreatic neuroendocrine tumors (including carcinoid tumors) are now staged by a single pancreatic staging system. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C90284:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exocrine and Endocrine Pancreatic Cancer TNM Finding v7","conceptCode":"C90284","definition":"A finding about one or more characteristics of exocrine or endocrine pancreatic cancer, following the rules of the TNM AJCC v7 classification system.  Pancreatic neuroendocrine tumors (including carcinoid tumors) are now staged by a single pancreatic staging system. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF79FA5D-505E-89D9-E040-BB89AD435E8F","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"ONEDATA","dateModified":"2012-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C73D1D5A-D2FC-BF4E-E040-BB89AD431197","latestVersionIndicator":"Yes","beginDate":"2012-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"COOPERM","dateModified":"2012-08-14","changeDescription":"Created and released for CRF standard harmonization. mc 5/15/12 Changed PVs to be consistent with other Stage standard CDEs. mc 8/14/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3451697","version":"1","longName":"Pancreas","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104994","version":"1","longName":"RTOG-1201","context":"NRG"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000602","version":"1","longName":"Pancreatic","context":"NCI Standards"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"PANC_TUM_C_GRP_STG","type":"Context Short Name","context":"CTEP"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"3452385v1.0:3452475v1.1","type":"USED_BY","context":"NRG"},{"name":"MCL","type":"USED_BY","context":"MCL"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"C73D1D5A-D460-BF4E-E040-BB89AD431197","latestVersionIndicator":"Yes","beginDate":"2012-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-08-14","modifiedBy":"COLBERTM","dateModified":"2021-10-12","changeDescription":"10/12/21 mr Removed MCL PCA pancreas CSI per DCT.   Created for CRF standard harmonization. Released per final community approval. mc 5/15/12 Versioned for changes to PVs in VD. mc 8/14/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}